Scholars Central

OpinionPublished 30 Jan 2025

Exploring the Pathophysiology of Alzheimer's Disease: Insights into Amyloid and Tau Pathways

Authors: Hong Chen

Department of Neurology, Izmir Katip Celebi University, Turkey

Journal of Dementia

Volume 9 · Issue 1 · Pages 1–2

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Alzheimer’s disease (AD) is a progressive neurodegenerative disorder characterized by cognitive decline and memory loss. The pathophysiology of AD is primarily associated with amyloid-beta (Aβ) plaques and tau protein tangles, which contribute to synaptic dysfunction, neuroinflammation, and neuronal loss. Amyloid pathology results from the improper cleavage of amyloid precursor protein (APP), leading to Aβ aggregation and plaque formation. Tau pathology is marked by hyperphosphorylation of tau protein, causing microtubule destabilization and neurofibrillary tangle (NFT) accumulation. These pathways interact to exacerbate neuronal dysfunction and cell death. Recent research highlights the roles of neuroinflammation, oxidative stress, and genetic predisposition in the progression of AD. Understanding these mechanisms provides insights into potential therapeutic strategies, including amyloid-targeting agents, tau inhibitors, and neuroprotective treatments. This review explores the amyloid and tau pathways, their interconnections, and implications for future interventions in AD management.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Dementia
  • SubjectNeuroscience & Neurology
  • BylineArticles whose byline prints “Hong Chen”